Key states, including California and Texas, lead in demand due to advanced healthcare systems and aging populations U.S. Embolic Protection Device Market U.S. Embolic Protection Device Market Dublin, ...

Use of embolic protection devices during saphenous vein graft (SVG) interventions is associated with an increase in procedural complications without corresponding improvements in clinical outcomes for ...

New York, USA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Global Embolic Protection Devices Market Set to Experience Unprecedented Growth at a CAGR of ~8% by 2032 | DelveInsight The demand for embolic ...

Please provide your email address to receive an email when new articles are posted on . Routine cerebral embolic protection did not reduce stroke in patients undergoing transcatheter aortic valve ...

PARIS, France—Embolic protection devices in TAVR appear to reduce the 30-day risk of stroke but do not affect 30-day mortality, according to a meta-analysis presented today at EuroPCR 2018. And while ...

ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — In PROTECTED TAVR, the largest-ever randomized trial of transcatheter aortic valve replacement, ...

RESIST is a small, but certainly interesting study that may help us improve the outcomes of patients who undergo renal artery revascularization with stents. Stenting is a common, albeit controversial, ...

Covidien's SpiderFX is the only embolic protection device in the U.S. indicated for use in the lower extremities. (Photo: Business Wire) Embolic protection devices are used to capture and remove ...

The recall was initiated following reports of 9 device malfunctions. Cardiovascular Systems Inc. has issued a voluntary recall of unused WIRION ® Embolic Protection systems due to complaints of filter ...

A multicenter EPIC (FiberNet Embolic Protection System in Carotid Artery Stenting Trial) study found that the FiberNet Embolic Protection System had a 97.5 percent success rate when used in patients ...

WASHINGTON, DC — Are surrogate end points enough to recommend a treatment that seems safe but hasn't "worked" by clinical-trial standards, but many agree ought to work? A pair of catheter-delivered ...